Saltar al contenido
Merck

Prior extended daily access to cocaine elevates the reward threshold in a conditioned place preference test.

Addiction biology (2013-05-03)
Zu-In Su, Jennifer Wenzel, Aaron Ettenberg, Osnat Ben-Shahar
RESUMEN

We have previously shown that extended-access subjects exhibit heightened motivation for cocaine in the runway model, as reflected by reduced number of retreats. This heightened motivation could reflect either an increase in cocaine-induced reward or a decrease in cocaine-induced aversion. The current experiment was therefore devised to assess the cocaine-induced reward and aversion in extended-access rats using a place conditioning test. Rats trained to lever press for intravenous (IV) cocaine (0.25 mg/infusion) were provided 6-hour daily access to the drug over 10 days. Lever pressing in control subjects produced IV infusions of saline. Following drug self-administration, subjects underwent place conditioning for the immediate or delayed effects of cocaine (1.0 or 2.5 mg/kg, IV). In control subjects, the immediate effects of the low dose of cocaine produced conditioned places preferences (CPPs), while the delayed effects produced conditioned place aversions (CPAs). In contrast, the animals receiving low cocaine dose for 6 hours, exhibited place aversions but not preferences; an effect that was reversed when the dose of cocaine was increased. Additionally, in the 6-hour group, delayed conditioning was associated with a reduction in zif268 immunoreactivity in the medial prefrontal cortex and nucleus accumbens shell while immediate conditioning was associated with an increase in zif268-positive cells in the central nucleus of the amygdala. Collectively, these data suggest that extended daily access to cocaine produces a shift in the subject's perceived reward threshold that is paralleled by alterations in the activity of both the reward and stress pathways.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Dimetilsulfóxido, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimetilsulfóxido, Molecular Biology
Sigma-Aldrich
Dimetilsulfóxido, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Dimetilsulfóxido, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Peróxido de hidrógeno solution, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Dimetilsulfóxido, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
Peróxido de hidrógeno solution, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Dimetilsulfóxido, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
3,3′-Diaminobencidina tetrahydrochloride hydrate, ≥96%
Millipore
Peróxido de hidrógeno solution, 3%, suitable for microbiology
Supelco
Peróxido de hidrógeno solution, ≥30%, for trace analysis
Sigma-Aldrich
Dimetilsulfóxido, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
Goat Serum Donor Herd, USA origin, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Dimetilsulfóxido, PCR Reagent
Sigma-Aldrich
Peróxido de hidrógeno solution, 34.5-36.5%
Supelco
Peróxido de hidrógeno solution, 30 % (w/w), for ultratrace analysis
Supelco
Dimetilsulfóxido, analytical standard
Supelco
Dimetilsulfóxido, for inorganic trace analysis, ≥99.99995% (metals basis)
USP
Dimetilsulfóxido, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Peróxido de hidrógeno solution, tested according to Ph. Eur.
Dimetilsulfóxido, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Dimetilsulfóxido, ≥99.6%, ReagentPlus®